Inhibiting neuropeptide Y Y1 receptor modulates melanocortin receptor- and NF-κB-mediated feeding behavior in phenylpropanolamine-treated rats

Hormones and Behavior

Volumn 64, Issue 1, 2013, Pages 95-102

  Hsieh, Yih Shou ^a   Chen, Pei Ni ^a   Yu, Ching Han ^a   Liao, Jiuan Miaw ^a   Kuo, Dong Yih ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Hypothalamus; MC4R; NF B; NPY; NPY Y1 receptor

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELANOCORTIN 4 RECEPTOR; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; PHENYLPROPANOLAMINE; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; APPETITE; ARTICLE; CONTROLLED STUDY; DECREASED APPETITE; DRUG MECHANISM; FEEDING BEHAVIOR; FOOD INTAKE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; HYPOTHALAMUS; INCREASED APPETITE; MALE; MC4R GENE; NEUROMODULATION; NFKAPPAB GENE; NONHUMAN; NPY GENE; NPY1R GENE; POMC GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR BLOCKING; TREATMENT OUTCOME; WEIGHT CHANGE;

ANIMALS; ANTISENSE ELEMENTS (GENETICS); APPETITE DEPRESSANTS; BLOTTING, WESTERN; BODY WEIGHT; CATHETERIZATION; CEREBRAL VENTRICLES; FEEDING BEHAVIOR; HYPOTHALAMUS; INFERIOR COLLICULI; INJECTIONS; MALE; NF-KAPPA B; PHENYLPROPANOLAMINE; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, MELANOCORTIN; RECEPTORS, NEUROPEPTIDE Y;

EID: 84879017854     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.05.005     Document Type: Article

References (64)

1. Acuna-Goycolea C., van den Pol A.N. Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. J. Neurosci. 2005, 25:10510-10519.
2. Andrews Z.B., Liu Z.W., Walllingford N., Erion D.M., Borok E., Friedman J.M., et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature 2008, 454:846-851.
3. Boersma M.C., Meffert M.K. Novel roles for the NF-kappaB signaling pathway in regulating neuronal function. Sci. Signal. 2008, 12,1(6):pe7.
4. Brothers S.P., Wahlestedt C. Therapeutic potential of neuropeptide Y (NPY) receptor ligands. EMBO Mol. Med. 2010, 2:429-439.
5. Butler R.K., White L.C., Frederick-Duus D., Kaigler K.F., Fadel J.R., Wilson M.A. Comparison of the activation of somatostatin- and neuropeptide Y-containing neuronal populations of the rat amygdala following two different anxiogenic stressors. Exp. Neurol. 2012, 238:52-63.
6. Chee M.J., Colmers W.F. Y eat?. Nutrition 2008, 24:869-877.
7. Chee M.J., Myers M.G., Price C.J., Colmers W.F. Neuropeptide Y suppresses anorexigenic output from the ventromedial nucleus of the hypothalamus. J. Neurosci. 2010, 30:3380-3390.
8. Cheng J.T., Kuo D.Y. Both α1-adrenergic and D1-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Neurosci. Lett. 2003, 347:136-138.
9. Cohen H., Liu T., Kozlovsky N., Kaplan Z., Zohar J., Mathé A.A. The Neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2012, 37:350-363.
10. Cowley M.A., Pronchuk N., Fan W., Dinulescu D.M., Colmers W.F., Cone R.D. Integration of NPY, AGRP, and melanocortin signals in the hypothalamic paraventricular nucleus: evidence of a cellular basis for the adipostat. Neuron 1999, 24:155-163.
11. Eva C., Serra M., Mele P., Panzica G., Oberto A. Physiology and gene regulation of the brain NPY Y1 receptor. Front. Neuroendocrinol. 2006, 27:308-339.
12. Fan W., Dinulescu D.M., Butler A.A., Zhou J., Marks D.L., Cone R.D. The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000, 141:3072-3079.
13. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
14. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
15. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. 1995, 59:201-205.
16. Hendriksen H., Bink D.I., Daniels E.G., Pandit R., Piriou C., Slieker R., Westphal K.G., Olivier B., Oosting R.S. Re-exposure and environmental enrichment reveal NPY-Y1 as a possible target for post-traumatic stress disorder. Neuropharmacology 2012, 63:733-742.
17. Henn I.H., Bouman L., Schlehe J.S., Schlierf A., Schramm J.E., Wegener E., et al. Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling. J. Neurosci. 2007, 27:1868-1878.
18. Horvath T.L., Naftolin F., Kalra S.P., Leranth C. Neuropeptide-Y innervation of beta endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. Endocrinology 1992, 131:2461-2467.
19. Horvathm T.L., Andrewsm Z.B., Diano S. Fuel utilization by hypothalamic neurons: roles for ROS. Trends Endocrinol. Metab. 2009, 20:78-87.
20. Hsieh Y.S., Yang S.F., Chu S.C., Kuo D.Y. Transcript of protein kinase A knock down modulates feeding behavior and neuropeptide Y gene expression in phenylpropanolamine-treated rats. Physiol. Genomics 2007, 31:306-314.
21. Hsieh Y.S., Yang S.F., Chiou H.L., Kuo D.Y. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression. Behav. Neurosci. 2007, 121:933-940.
22. Hsieh Y.S., Yang S.F., Chu S.C., Kuo D.Y. Interrupting activator protein-1 signaling in conscious rats can modify neuropeptide Y gene expression and feeding behavior of phenylpropanolamine. J. Neurochem. 2008, 104:50-61.
23. Hsieh Y.S., Chen P.N., Kuo M.H., Kuo D.Y. The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase of oxidative stress and appetite suppression. NeuroMolecular Med. 2013, 15:159-168.
24. Jaillard T., Roger M., Galinier A., Guillou P., Benani A., Leloup C., et al. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism. Diabetes 2009, 58:1544-1549.
25. Jang P.G., Namkoong C., Kang G.M., Hur M.W., Kim S.W., et al. NF-kappaB activation in hypothalamic pro-opiomelanocortin neurons is essential in illness- and leptin-induced anorexia. J. Biol. Chem. 2010, 285:9706-9715.
26. Kuo D.Y., Yang S.F., Chu S.C., Chen C.H., Hsieh Y.S. Roles of protein kinase C-α isozyme in the regulation of oxidative stress and neuropeptide Y gene expression in phenylpropanolamine-mediated appetite suppression. J. Neurochem. 2009, 108:1495-1506.
27. Kuo D.Y., Yang S.F., Chu S.C., Chen C.H., Hsieh Y.S. Amphetamine-evoked changes of oxidative stress and neuropeptide Y gene expression in hypothalamus: regulation by the protein kinase C-delta signaling. Chem. Biol. Interact. 2009, 180:193-201.
28. Kuo D.Y., Yang S.F., Chu S.C., Chen C.H., Chen P.N., Hsieh Y.S. The effect of protein kinase C-delta knockdown on anti-free radical enzyme and neuropeptide Y gene expression in phenylpropanolamine-treated rats. J. Neurochem. 2010, 114:1217-1230.
29. Kuo D.Y., Chen P.N., Yang S.F., Chu S.C., Chen C.H., Kuo M.S., Yu C.H., Hsieh Y.S. Role of reactive oxygen species-related enzymes in neuropeptide Y and proopiomelanocortin-mediated appetite control: a study using atypical protein kinase C knockdown. Antioxid. Redox Signal. 2011, 15:2147-2159.
30. Kuo D.Y., Chen P.N., Chu S.C., Hsieh Y.S. Knocking down the transcript of NF-kappaB modulates the reciprocal regulation of endogenous antioxidants and feeding behavior in phenylpropanolamine-treated rats. Arch. Toxicol. 2012, 86:453-463.
31. Kuo D.Y., Chen P.N., Yu C.H., Kuo M.H., Hsieh Y.S., Chu S.C. Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression. Neuropharmacology 2012, 63:842-850.
32. Lee N.J., Nguyen A.D., Enriquez R.F., Doyle K.L., Sainsbury A., Baldock P.A., Herzog H. Osteoblast specific Y1 receptor deletion enhances bone mass. Bone 2011, 48:461-467.
33. Mashiko S., Moriya R., Ishihara A., Gomori A., Matsushita H., Egashira S., Iwaasa H., Takahashi T., Haga Y., Fukami T., Kanatani A. Synergistic interaction between neuropeptide Y1 and Y5 receptor pathways in regulation of energy homeostasis. Eur. J. Pharmacol. 2009, 615:113-117.
34. Mattson M.P., Calmandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 2001, 107:247-254.
35. Mercer R.E., Chee M.J., Colmers W.F. The role of NPY in hypothalamic mediated food intake. Front. Neuroendocrinol. 2011, 32:398-415. (Review).
36. Michel M.C., Beck-Sickinger A., Cox H., et al. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998, 50:143-150.
37. Millington G.W. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutr. Metab. (Lond.) 2007, 4:18.
38. Morales-Medina J.C., Dumont Y., Quirion R. A possible role of neuropeptide Y in depression and stress. Brain Res. 2010, 1314:194-205.
39. Morris G., Maes M. Increased nuclear factor-κB and loss of p53 are key mechanisms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med. Hypotheses 2012, 79:607-613.
40. Moynagh P.N. The NF-κB pathway. J. Cell Sci. 2005, 118:4389-4392.
41. Nguyen A.D., Herzog H., Sainsbury A. Neuropeptide Y and peptide YY: important regulators of energy metabolism. Curr. Opin. Endocrinol. Diabetes Obes. 2011, 18:56-60.
42. Ogawa S., Pfaff D.W. Current status of antisense DNA methods in behavioral studies. Chem. Senses 1998, 23:249-255.
43. O'Shea D., Morgan D.G., Meeran K., Edwards C.M., Turton M.D., Choi S.J., et al. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 1997, 138:196-202.
44. Parsons A.C., Shraim M., Inglis J., Aveyard P., Hajek P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst. Rev. 2009, 1:CD006219.
45. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney, Australia. 2nd ed.
46. Penzner J.H., Thompson D.L., Arth C., Fowler J.K., Ary A.W., Szumlinski K.K. Protracted 'anti-addictive' effects of adolescent phenylpropanolamine exposure in C57BL/6J mice. Addict. Biol. 2008, 13:310-325.
47. Pilsczek F.H., Karcic A.A., Freeman I. Case report: dexatrim (phenylpropanolamine) as a cause of myocardial infarction. Heart Lung 2003, 32:100-104.
48. Pjetri E., Adan R.A., Herzog H., de Haas R., Oppelaar H., Spierenburg H.A., Olivier B., Kas M.J. NPY receptor subtype specification for behavioral adaptive strategies during limited food access. Genes Brain Behav. 2012, 11:105-112.
49. Pronchuk N., Beck-Sickinger A.G., Colmers W.F. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus. Endocrinology 2002, 143:535-543.
50. Ritter R.C., Slusser P.G., Stone S. Glucoreceptors controlling feeding and blood glucose: location in the hindbrain. Science 1981, 213:451-452.
51. Roseberry A.G., Liu H., Jackson A.C., Cai X., Friedman J.M. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron 2004, 41:711-722.
52. Rudolf K., Eberlein W., Engel W., Wieland H.A., Willim K.D., Entzeroth M., Wienen W., Beck Sickinger A.G., Doods H.N. The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP 3226. Eur. J. Pharmacol. 1994, 271:R11-R13.
53. Schöbitz B., Pezeshki G., Probst J.C., Reul J.M., Skutella T., Stöhr T., Holsboer F., Spanagel R. Centrally administered oligodeoxynucleotides in rats: occurrence of non-specific effects. Eur. J. Pharmacol. 1997, 331:97-107.
54. Sparrow A.M., Lowery-Gionta E.G., Pleil K.E., Li C., Sprow G.M., Cox B.R., Rinker J.A., Jijon A.M., Peňa J., Navarro M., Kash T.L., Thiele T.E. Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors. Neuropsychopharmacology 2012, 37:1409-1421.
55. Takayasu S., Iwasaki Y., Nigawara T., Asai M., Yoshida M., Kageyama K., Suda T. Involvement of nuclear factor-kB and Nurr-1 in cytokine-induced transcription of proopiomelanocortin gene in AtT20 corticotroph cells. Neuroimmunomodulation 2010, 17:88-96.
56. Tsakiris P., de la Rosette J.J., Michel M.C., Oelke M. Pharmacologic treatment of male stress urinary incontinence: systematic review of the literature and levels of evidence. Eur. Urol. 2008, 53:53-59.
57. Wellman P.J., Davies B.T. Reversal of cirazoline- and phenylpropanolamine-induced anorexia by the alpha 1-receptor antagonist prazosin. Pharmacol. Biochem. Behav. 1992, 42:97-100.
58. Widnell K.L., Self D.W., Lane S.B., Russell D.S., Vaidya V., Miserendino M.J.D., et al. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J. Pharmacol. Exp. Ther. 1996, 276:306-315.
59. Winders S.E., Amos J.C., Wilson M.R., Rushing P.A., Dykstra T., Coday M.C. Effects of chronic phenylpropanolamine infusion and termination of body weight, food consumption and water consumption in rats. Psychopharmacology 1994, 114:513-519.
60. Wu Q., Palmiter R.D. GABAergic signaling by AgRP neurons prevents anorexia via a melanocortin-independent mechanism. Eur. J. Pharmacol. 2011, 660:21-27.
61. Wyss P., Stricker-Krongrad A., Brunner L., Miller J., Crossthwaite A., Whitebread S., Criscione L. The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes. Regul. Pept. 1998, 75-76:363-371.
62. Yang L., Tao L.Y., Chen X.P. Roles of NF-kappaB in central nervous system damage and repair. Neurosci. Bull. 2007, 23:307-313.
63. Yulyaningsih E., Zhang L., Herzog H., Sainsbury A. NPY receptors as potential targets for anti-obesity drug development. Br. J. Pharmacol. 2011, 163:1170-1202.
64. Zhang M., Creese I. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates. Neurosci. Lett. 1993, 161:223-226.